Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Esophageal Squamous Carcinoma Cell”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableWithdrawnNCT06420908
What this trial is testing

Adebrelimab Combined With Chemoradiotherapy for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma (ESCC)

Who this might be right for
Esophageal Squamous Cell Carcinoma
Hebei Medical University Fourth Hospital
Early research (Phase 1)Looking for participantsNCT07229313
What this trial is testing

KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Advance Solid Tumors
Kivu Bioscience Inc. 76
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05732662
What this trial is testing

SBRT Combined With AK104 to Treatment Relapsed or Metastatic ESCC

Who this might be right for
Recurrent or Metastatic Esophageal Squamous Cell Carcinoma
The First People's Hospital of Changzhou 25
Testing effectiveness (Phase 2)Looking for participantsNCT06753747
What this trial is testing

A Trial of the Combination of Afatinib and Palbociclib in Previously Treated Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophagus Cancer
West China Hospital 45
Testing effectiveness (Phase 2)UnknownNCT01336049
What this trial is testing

Nimotuzumab Plus Paclitaxel and Cisplatin as 1st Line Treatment for Esophageal Squamous Cell Cancer

Who this might be right for
Esophageal Squamous Cell Cancer
Peking University 70
Testing effectiveness (Phase 2)Looking for participantsNCT05592626
What this trial is testing

A Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsGenital Neoplasm, FemaleUrogenital Neoplasms+11 more
Marengo Therapeutics, Inc. 366
Not applicableStudy completedNCT04936399
What this trial is testing

Participants With Squamous Cell Oesophageal Carcinoma Receiving Nivolumab as Part of an Early Access to Medicines Scheme (EAMS) Program in the United Kingdom

Who this might be right for
Esophageal Squamous Cell Carcinoma
Bristol-Myers Squibb 87
Testing effectiveness (Phase 2)Study completedNCT03187314
What this trial is testing

Combination of Radiation Therapy and Anti-PD-1 Antibody SHR-1210 in Treating Patients With Esophageal Cancer

Who this might be right for
Esophageal NeoplasmsEsophageal DiseasesEsophageal Squamous Cell Carcinoma
Hangzhou Cancer Hospital 25
Testing effectiveness (Phase 2)Looking for participantsNCT03526835
What this trial is testing

Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced/Metastatic Solid TumorsColorectal CancerGastric Cancer+5 more
Merus B.V. 560
Large-scale testing (Phase 3)UnknownNCT02319187
What this trial is testing

Irinotecan Plus S1 Versus S1 in Patients With Previously Treated Advanced Esophageal Cancer: ESWN 01 Trial

Who this might be right for
Esophageal Neoplasms
Chinese Academy of Medical Sciences 240
Testing effectiveness (Phase 2)UnknownNCT03126708
What this trial is testing

Cetuximab in Combination With Paclitaxel Plus Cisplatin Versus Paclitaxel Plus Cisplatin Alone for the First-line Treatment of Metastatic Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Cancer, Squamous CellCetuximab EffectChemotherapy Effect
Peking University 150
Not applicableLooking for participantsNCT06476067
What this trial is testing

Predicting Early Tumor Recurrence in Patients With Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal CancerRecurrenceDNA Methylation
City of Hope Medical Center 150
Not applicableStudy completedNCT03304132
What this trial is testing

The Oral Microbiome and Upper Aerodigestive Squamous Cell Cancer

Who this might be right for
Oral Cancer
NYU Langone Health 560
Testing effectiveness (Phase 2)UnknownNCT04797507
What this trial is testing

SHR-1210 in Combination With Anlotinib in Patients With Advanced or Metastatic Esophageal Squamous Cell Cancer

Who this might be right for
SHR-1210AnlotinibAdvanced Esophageal Squamous Cell Cancer
Peking Union Medical College Hospital 33
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06178211
What this trial is testing

Neoadjuvant Adebrelimab Plus Chemotherapy for Resectable ESCC: a Single Arm, Prospective Phase 2 Clinical Trial

Who this might be right for
Esophageal Squamous Cell Carcinoma
Shanghai Chest Hospital 36
Testing effectiveness (Phase 2)UnknownNCT06464614
What this trial is testing

Adebrelimab in Combination With Apatinib and Chemotherapy/Chemoradiotherapy in Immuno-experienced Second-line ESCC.

Who this might be right for
Esophageal Cancer
The First Affiliated Hospital of Henan University of Science and Technology 54
Testing effectiveness (Phase 2)Temporarily pausedNCT04084158
What this trial is testing

Toripalimab Combined With Concurrent Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma.

Who this might be right for
Esophageal Squamous Cell Carcinoma
Zhejiang Cancer Hospital 100
Testing effectiveness (Phase 2)Study completedNCT00072033
What this trial is testing

Neoadjuvant Docetaxel and Cisplatin Plus Chemoradiotherapy Followed By Surgery in Treating Patients With Locally Advanced, Resectable Esophageal Cancer

Who this might be right for
Esophageal Cancer
Swiss Cancer Institute 66
Testing effectiveness (Phase 2)UnknownNCT03387904
What this trial is testing

Study of Anlotinib Plus Irinotecan in Patients With Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
The First Affiliated Hospital of Zhengzhou University 120
Early research (Phase 1)Study completedNCT00004178
What this trial is testing

Gene Therapy in Treating Patients With Cancer

Who this might be right for
Cancer
Roger Williams Medical Center
Next Page